Nov 14, 2026 · 7 min read
Aromatase Inhibitors: Arimidex and Aromasin Doses
Best Anabolic Steroids
Independent research & quality review desk
Aromatase inhibitors are prescribed medicines that block the enzyme converting testosterone into estradiol. On a cycle they are used to bring high estrogen down, and the dose that does that is far smaller than the label suggests. Most problems with them come from taking one as a precaution and pushing estrogen below the range the body needs.
- They block aromatase, the enzyme that makes estradiol from testosterone.
- Anastrozole comes as a 1 mg tablet with a half-life of about 47 hours.
- Exemestane is a steroidal inhibitor, supplied as a 25 mg tablet.
- Doses used by men on a cycle are a fraction of the labelled dose.
- Estrogen is needed for joints, libido, bone and lipids; zero is not the goal.
What they do
Aromatase is the enzyme that converts testosterone into estradiol. An aromatase inhibitor blocks it, so less testosterone is converted and circulating estradiol falls. That is different from a SERM such as tamoxifen or clomiphene, which blocks the estrogen receptor without changing how much estrogen is present.
The difference matters. A SERM changes where estrogen acts; an inhibitor changes how much exists. They are not interchangeable, and using both at once is a way to lose control of the picture.
Anastrozole
The labelled product is a 1 mg tablet taken once daily, and the terminal elimination half-life is about 47 hours. That long half-life is why a small dose is enough and why effects accumulate if it is taken daily.
| Item | Detail |
|---|---|
| Tablet strength | 1 mg |
| Labelled dose | 1 mg once daily, in a different clinical context |
| Half-life | About 47 hours |
| Reported use by men on a cycle | 0.25 to 0.5 mg every other day, adjusted by blood work |
Exemestane
Exemestane is a steroidal inhibitor: it binds aromatase irreversibly, so the enzyme has to be replaced rather than simply released. It comes as a 25 mg tablet, which is even further from the doses used by men on a cycle, and the irreversibility means an overshoot takes longer to correct.
Its advantage in principle is that it does not interact with the estrogen receptor at all, and its disadvantage in practice is that the tablet is too large for the doses used, so precise dosing is harder.
Which one
| Anastrozole | Exemestane | |
|---|---|---|
| Type | Non-steroidal, reversible | Steroidal, irreversible |
| Tablet | 1 mg | 25 mg |
| Half-life | About 47 hours | Shorter, with sustained enzyme blockade |
| Practical use | Easier to divide into small doses | Harder to divide, longer to reverse |
Why not as a precaution
Estrogen is not a waste product in men. It is needed for bone density, for joint comfort, for libido and for a healthy lipid profile. Blocking it when it is not high produces a recognisable set of problems: dry painful joints, loss of libido, low mood, and over time an effect on bone.
When to act
| Situation | Reasonable step |
|---|---|
| No symptoms, estradiol in range | Nothing. Test again at the next scheduled point |
| Estradiol high on the panel, no symptoms | Review dose and body fat first; a smaller testosterone dose may solve it |
| Sensitive nipples, visible swelling | Act with blood work, under medical supervision |
| Low libido, dry joints, low estradiol | Stop the inhibitor, do not add anything |
Blood work
Estradiol must be measured with a sensitive assay, because standard immunoassays are unreliable at the low concentrations men have. Timing matters too: the sample should be taken at a consistent point relative to the injection, so results can be compared.
- Baseline before the cycle.
- Mid-cycle, at a fixed point after the injection.
- Whenever symptoms appear, rather than guessing.
If estrogen is too low
The signs are joint pain, flat libido, fatigue and low mood, and a blood test that shows estradiol under the reference range. The response is to stop the inhibitor, not to add anything else, and to let the level recover as the enzyme resumes normal function. With exemestane this takes longer, because the enzyme has to be replaced.
Common mistakes
- Starting an inhibitor on day one of a cycle, before any blood work exists.
- Using a whole 1 mg tablet because the tablet is the smallest unit sold.
- Adding a SERM at the same time, so two different mechanisms are pulling at once.
- Judging estrogen by symptoms alone when a sensitive assay costs one blood draw.
- Stopping cold after a long run and expecting the level to return the next day; with exemestane it takes longer.
Legal status
Both drugs are prescription medicines, licensed for breast cancer treatment, and used off-label in men for fertility and hormone management. Buying them without a prescription for cycle support is outside any licensed indication, and the blood work that makes them safe is the part that gets skipped most often.
Where to read next
- Post-cycle therapy - SERMs, which work differently from inhibitors.
- Testosterone cycle - where estrogen control fits into a layout.
- hCG in recovery - the other hormone people add without a plan.
- Post-cycle shelf - products in the catalogue.
Frequently Asked Questions
Sources
- DailyMed: anastrozole label - 1 mg tablets, one tablet daily, terminal elimination half-life of about 47 hours.
- DailyMed: exemestane label - 25 mg tablets and the product description.
- PubMed 16352679 - selective testosterone and estradiol withdrawal and skeletal sensitivity, the basis for the bone warning.
- PubMed 34871401 - clinical application of aromatase inhibitors in male infertility, where the human data in men actually sits.
- PubMed 36217397 - anastrozole in subfertile men, response by testosterone to estradiol ratio.
